Sequel Med Tech, LLC
$5.1K 64 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Alcon Puerto Rico Inc
Alcon Puerto Rico Inc reported $5,034.89 across General Payments, Research, and Ownership to 79 physicians and teaching hospitals across 79 transactions.
- $5.0K Below-median payer
- All-tracks total
- 79 Below-median volume
- Transactions
- 79 Below-median reach
- Recipients
- −$6.9K
- General Payments vs PY2023
Alcon Puerto Rico Inc reported $5,034.89 across all CMS Open Payments tracks (General + Research + Ownership) to 79 physicians and teaching hospitals in Program Year 2024 - ranking #1710 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $5,034.89, averaging $63.73 per recipient.
Alcon Puerto Rico Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer alcon-puerto-rico-inc Alcon Puerto Rico Inc
$5.0K · #1710/1,925 · 0.0% industry · PY2024
- TOT $5.0K
- RANK #1710
- SHARE 0.0%
- TXN 79
- RCP 79
- CAT 1
- GEN $5.0K
- ΔGEN −$6.9K
- TOP1 5.2%
- PY 2024
Volume peers
Nearest volume peer: Sequel Med Tech, LLC ($5.1K)
Alcon Puerto Rico Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Alcon Puerto Rico Inc's CMS-reported General Payments decreased by $6.9K (−58.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ALCON PUERTO RICO INCPY2023: ALCON PUERTO RICO INCPY2024: Alcon Puerto Rico Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $11,978.41
- PY2024
- $5,034.89
What the Data Shows for Alcon Puerto Rico Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Alcon Puerto Rico Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $5.0K across 79 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Alcon Puerto Rico Inc's 1-category general-payment breakdown at $5.0K, 100.0% of the reported total.
How Alcon Puerto Rico Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $5.0K | 79 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,205.93 (24.0%) of $5,034.89 in this company's General Payments records across 54 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Alcon Puerto Rico Inc
The five named recipients with the highest reported General Payments from this company
- 1
Luis a Rivera Rodriguez
$261.67 across 2 reported transactions
- 2
Luis Manuel Cruz Cruz
$261.67 across 2 reported transactions
- 3
Ricardo Miguel Santaella
$261.67 across 2 reported transactions
- 4
Elsie N de la Texera
$256.81 across 6 reported transactions
- 5
Hector M Mayol
$164.11 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Alcon Puerto Rico Inc's spend rank (#1710 of 1,925, bottom 11% by spend) and concentration rank (#1,468 of 1,838, bottom 20% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Avanos Medical : $867.2K total payments, HHI 298
- Atland Pharmaceuticals, LLC : $7.0K total payments, HHI 296
- Si-Bone, Inc. : $8.1M total payments, HHI 291
- Linde Gas & Equipment Inc. : $116.7K total payments, HHI 290
- Solventum Corporation : $6.0M total payments, HHI 289
- Enterra Medical, Inc. : $447.0K total payments, HHI 289
- Alcon Puerto Rico Inc (this company) : $5.0K total payments, HHI 288
- Prime Surgical, LLC : $40.5K total payments, HHI 288
- Alimera Sciences, Inc. : $791.8K total payments, HHI 287
- Bioventus LLC : $1.1M total payments, HHI 286
- Mayne Pharma Commercial LLC : $1.3M total payments, HHI 286
- IRRAS USA, Inc. : $15.1K total payments, HHI 285
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Alcon Puerto Rico Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Alcon Puerto Rico Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Alcon Puerto Rico Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Genetics Institute LLC
$5.0K 2 recipients
Compare payment profiles
Hand Biomechanics Laboratory
$5.0K 1 recipients
Compare payment profiles
The Binding Site Inc.
$5.0K 21 recipients
Compare payment profiles
Fusion Orthopedics, LLC.
$5.0K 17 recipients
Compare payment profiles
Vifor Fresenius Medical Care Renal Pharma Ltd.
$5.0K 2 recipients
Compare payment profiles
Put this to use
Alcon Puerto Rico Inc ranks #1710 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Alcon Puerto Rico Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.